Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Evaxion A/S changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 143.5K | 92.9K | −50.6K (−35.2%) |
| Value | $377.0K | $166.9K | −$210.1K (−55.7%) |
New holders (4)
Institutions that held Evaxion A/S at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ground Swell Capital, LLC | 18,071 | $32.5K | 0.14% |
| Pura Vida Investments, LLC | 16,842 | $29.9K | 0.01% |
| Beacon Capital Management, LLC | 6,881 | $12.2K | 0.00% |
| Group One Trading, L.P. | 3,340 | $6.01K | 0.00% |
Sold out (2)
Institutions that held Evaxion A/S at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Steward Partners Investment Advisory, LLC | 1,000 | $3.00K |
| Cutler Group LP | 200 | $0 |